Company intelligence / Profile preview

Emerald Clinical

Ownership: Private
Employees: ~500
Development stage: Other

Overview

As a contract research organization (CRO), Emerald Clinical has no internal drug development pipeline or proprietary programs. It provides end-to-end services supporting client programs across all clinical development stages. The company has completed over 600+ clinical trials globally across multiple therapy areas and phases, including examples like Phase III vaccine trial management and Phase II oncology trial support.

Therapeutic areas: PulmonologyCardiovascularNephrologyEndocrinologyOncologyNeurology
Modalities: Small moleculeBiologicMonoclonal antibodyVaccineDevice
Industry: Contract Research Organization

Partnerships

Collaborates with sponsors worldwidePartnerships with KOLsPartnerships with national coordinators

Beyond the preview

Go deeper on Emerald Clinical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Emerald Clinical.

Explore the full profile